Three London shares are on the march and are anticipated to rise by greater than 50% over the subsequent 12 months. CNBC Professional screened for shares lined by analysts at RBC Capital Markets which have risen this yr, have momentum behind them, and have an upside potential of greater than 50%. Team17 Shares of Team17 , an England-based online game writer, may rise by 51.6% to £3.60 ($4.68) over the subsequent 12 months, based on RBC. British shares are priced in pence. 100 pence quantities to 1 British pound. Team17 says it publishes “indie video games developed by impartial builders.” RBC Capital Markets started protection of the inventory in July, citing a “premium” administration crew on the helm at Team17, a brand new technique and acquisitions as a key driver of development. “With a mixture of founder Debbie Bestwick’s indie experience, new CEO Steve Bell’s refreshed technique and clear messaging and new Chair Frank Sagnier’s expertise in each franchise constructing and M & A, we consider the group is properly positioned to drive each natural and inorganic development,” mentioned RBC analyst Ross Broadfoot in a word to purchasers on July 15. TM17-GB 1Y line Extra not too long ago, RBC mentioned the corporate reported “a very good set of outcomes” in September. The corporate reported £80.6 million in whole gross sales, lacking income expectations of £81.5 million marginally. Internet revenue got here in a lot greater than anticipated at £19.2 million. “The share value has been weak in latest instances suggesting a warning, maybe pushed by the anticipated weaker new title efficiency. The group is making good strides towards its technique by way of price management and development in 1st get together IP with 150bps of margin accretion on the [adjusted earnings] degree,” Broadfoot added. Broadfoot has a hit fee of 75%, based on TipRanks. Which means three out of 4 scores the analyst revamped the previous yr made a revenue for traders. Team17 has a median value goal of £3.60, indicating a 51.6% upside. The inventory is up 28% this yr, Drax Group Shares of Drax , one of many U.Ok.’s largest energy plant operators, may soar over the subsequent yr by 65%, based on a forecast by RBC Capital Markets. In July, the corporate introduced a £300 million share buyback program, which amounted to almost 15% of the corporate’s market cap on the time. Subsequently, the inventory has risen by nearly 20% since. RBC’s Alexander Wheeler mentioned the funding financial institution was “constructive on the expansion within the core enterprise” at Drax, which primarily burns wooden pallets to generate electrical energy. Wheeler additionally famous that the inventory had “vital upside potential” after the corporate reported its first-half outcomes on July 26. Oxford Biomedica Shares of Oxford Biomedica can double regardless of having risen by greater than 70% this yr already, based on RBC. The funding financial institution has essentially the most bullish view amongst seven analysts masking the inventory. The corporate, spun out of the College of Oxford, focuses on gene and cell remedy. RBC analyst Charles Weston mentioned the inventory stays “materially undervalued” after the corporate reported its first half-year monetary outcomes. OXB mentioned gross sales for the primary half of 2024 had been up 18% to £51.8 million in comparison with final yr. RBC additionally mentioned the inventory may rise by 387% over the subsequent three years as the corporate turns worthwhile. “As OXB ought to flip meaningfully worthwhile in 2026 and will attain extra of a peak margin in 2028, we apply a 20x EV/[adjusted profit] (a slight premium to friends to replicate OXB’s greater anticipated development) to our estimate of 2028E [adjusted profit] for an implied end-2027 truthful worth of £18,” Wheeler mentioned in a word to purchasers on Sept 23.